Understanding how CD8 T cells respond to SARS-CoV-2 and their role in Long COVID
Official title: Elucidating the lineage dynamics of optimal human CD8 T cell responses to SARS-CoV-2 and how CD8 T cell homeostasis is altered in Long COVID
Funded at University of Pennsylvania · NIH-11083549 · Data updated 2026-11-12
This study is looking at how certain immune cells called CD8 T cells work to fight off COVID-19, especially in people who have lingering symptoms, to help find ways to improve vaccines and treatments for the virus and its long-term effects.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $83,224 |
| NIH project number | 5F32AI181343-02 |
| Project ID | NIH-11083549 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who have had COVID-19, especially those experiencing Long COVID symptoms.
✕Less likely to help
Patients who have not been infected with SARS-CoV-2 or do not exhibit any symptoms related to COVID-19 may not benefit from this research.
What this research studies
This research investigates the behavior of CD8 T cells, which are crucial for fighting viral infections like COVID-19. It aims to understand how these immune cells differentiate and respond to the virus, especially in individuals who experience Long COVID symptoms. By analyzing blood samples and immune responses, the study seeks to identify the factors that lead to effective or dysfunctional T cell responses. This knowledge could help in developing better vaccines and treatments for COVID-19 and its long-term effects.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for COVID-19 and Long COVID, enhancing patient recovery and quality of life.
How similar studies have gone: Other research has shown promise in understanding T cell responses to viral infections, indicating that this approach could yield valuable insights.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Painter, Mark M — University of Pennsylvania
- Study coordinator: Painter, Mark M
Related research
Other NIH-funded projects on the same topics.
-
Creating antibodies to study long-COVID in hamsters
This study is looking to create special antibodies that can help researchers learn more about how the immune system responds to long-COVID in hamsters, which could eventually help us understand the condition better for everyone.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.